| Abstract ID | Abstract Title | Presenting Author Name |
| 149 | Diagnostic Value, Predictive Significance and Kinetics of Faecal Calprotectin in Suspected Acute Gut GVHD / GVHD Flare Post Allogeneic Stem Cell Transplant | Rashmi Ranjan Pradhan |
| 140 | Pretransplant Host Status, Rather Than HLA Matching, Determines Hematopoietic stem cell transplant outcomes in Patients with Inborn Errors of Immunity | Mahafrin Homiar Goiporia |
| 119 | Benchmarking stem cell transplant survival outcomes in benign and malignant hematologic disorders: A cross-registry analysis of a North Indian single center with CIBMTR and EBMT data. | Himanshu |
| 77 | The impact of neurological complications in children undergoing haematopoietic stem cell transplantation – a retrospective analysis over two decades | Krithika Krishnakumar |
| 62 | Real-world outcomes of adults with acute lymphoblastic leukaemia (ALL) undergoing allogeneic transplantation: Multi-center data from the Indian Society of Blood and Marrow Transplant (ISBMT) | Punit Jain |
| 61 | A low cost preventive strategy for hepatic veno occlusive disease in class III thalassemia patients – a single center experience | Sohini Chakraborty |
| 60 | Comparison of conditioning regimens used for alternate donor hematopoietic stem cell transplantation in thalassemia - a single center experience from north India | Sohini Chakraborty |
| 55 | Outcomes of Autologous Stem-cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma – Is Less “Sufficient” and “Safe” in the MRD Era? | Sumeet Mirgh |
| 50 | Twenty-two years follow up on the incidence of malignancies in children post Hematopoietic Stem Cell Transplantation | Vijayshree Muthukumar |
| 47 | A pilot study to find an optimized option for platelet transfusion in pediatric stem cell transplant recipients | Divya Setya |
| 34 | Excellent thalassaemia free survival in haploidentical hematopoietic stem cell transplantation with myeloablative conditioning and posttransplant cyclophosphamide in older children with antibodies and transfusion dependent thalassemia – a retrospective co | Kavitha Ganesan |
| 25 | Fixed-Dose Pegylated G-CSF and Plerixafor: Faster, Safer Stem Cell Mobilisation | Sai Kiran |